Join our daily newsletter At The Bell to receive exclusive market insights
- Polynovo (PNV) says its NovoSorb BTM dressing has been applied to its first patients in the U.K.
- The company said several other British hospitals are in the process of selecting patients for surgeries
- It has also hired more staff for the expansion into Europe
- Polynovo is up 2.47 per cent on the Australian Securities Exchange today, selling shares at $2.90 apiece
Polynovo (PNV) has reported its NovoSorb BTM has been applied to its first patients in the U.K.
BTM is a synthetic dressing that is used to treat severe burns and wounds, where there is a significant loss of flesh.
The company says one of the patients was treated for Necrotising Fasciitis in an English National Health Service (NHS) hospital. A second patient was treated for a scalp defect.
Several other NHS hospitals are in the process of selecting patients for surgeries.
In anticipation of the launch, the company had stock in England. Over the past 14 months, Polynovo found a direct sales infrastructure and business processes in the UK, to be ready for the anticipated demand for BTM.
Polynovo has also appointed two additional sales staff in the U.K. and Ireland, and a Marketing Manager, who will be based in England.
The new staff are being inducted, and trained and are expected to be in the field early March.
Last week, the company received its first order of BTM in Germany, Austria, and Switzerland.
Polynovo has reported that its distributor, PMI, has placed a second order.
It has now achieved first surgeries in England Germany and Switzerland.
“Last week I visited several surgeons with our U.K. Sales Manager and I was impressed by the excitement that NovoSorb has generated,” CEO Paul Brennan said.
“The first surgeries in England so soon after registration are a reflection of doctor enthusiasm,” he added.
Chairman David Willian says Polynovo still gas a lot of work to do.
“We have a lot of work to do building our base from these early patients and in the meantime sales will be lumpy,” he told the market.
“We are also looking for good sales staff in many parts of Western Europe to make the most of our EU approval,” he added.
Polynovo is up 2.47 per cent on the Australian Securities Exchange today, selling shares at $2.90 apiece at 12:45 pm AEDT.
